Form 8-K · Current report
News Corp 8-K, filed Oct 7, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000217
Summary
News Corp reported daily buy-back activity to the Australian Securities Exchange under its US$1 billion 2025 Repurchase Program, repurchasing 62,323 shares for about US$1.78 million on 6 October 2026 and bringing cumulative purchases to roughly US$517.4 million. The program covers both its Nasdaq-listed Class A and Class B common stock and is described as intended to enhance shareholder value.
Key points
- News Corp repurchased 62,323 shares on 6 October 2026 for US$1,781,527.88, at prices between US$28.29 and US$28.98.
- Cumulative repurchases under the 2025 Repurchase Program total about US$517,422,870, against a US$1 billion authorization covering Class A and Class B common stock.
- The repurchases are made in the open market or otherwise and are intended to enhance shareholder value.
- Goldman Sachs & Co. LLC is named as broker, and the authorization dates from 15 July 2025.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.